122 related articles for article (PubMed ID: 30268582)
21. A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal.
Smith EI; Haase GM; Seeger RC; Brodeur GM
J Pediatr Surg; 1989 Apr; 24(4):386-90. PubMed ID: 2732883
[TBL] [Abstract][Full Text] [Related]
22. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.
Conter HJ; Gopalakrishnan V; Ravi V; Ater JL; Patel S; Araujo DM
Sarcoma; 2014; 2014():375151. PubMed ID: 25024639
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma in patients under 18 months. Single institution experience in Argentina.
Rossa A; Cacciavillano W; Rose A; Flores P; Chantada G; Zubizarreta P
Medicina (B Aires); 2019; 79(4):280-283. PubMed ID: 31487248
[TBL] [Abstract][Full Text] [Related]
24. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
[TBL] [Abstract][Full Text] [Related]
25. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
[TBL] [Abstract][Full Text] [Related]
26. Neuroblastoma: experience from National University Health System, Singapore (1987-2008).
Tan C; Sabai SM; Tin AS; Quah TC; Aung L
Singapore Med J; 2012 Jan; 53(1):19-25. PubMed ID: 22252178
[TBL] [Abstract][Full Text] [Related]
27. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
Castleberry RP; Shuster JJ; Smith EI
J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
[TBL] [Abstract][Full Text] [Related]
28. Fifteen years' experience of neuroblastoma: a prognostic evaluation according to the Evans and UICC staging systems.
Hata Y; Naito H; Sasaki F; Ohkawa M; Takeda T; Sasaki M; Uchino J
J Pediatr Surg; 1990 Mar; 25(3):326-9. PubMed ID: 2313503
[TBL] [Abstract][Full Text] [Related]
29. Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Pinto NR; Applebaum MA; Volchenboum SL; Matthay KK; London WB; Ambros PF; Nakagawara A; Berthold F; Schleiermacher G; Park JR; Valteau-Couanet D; Pearson AD; Cohn SL
J Clin Oncol; 2015 Sep; 33(27):3008-17. PubMed ID: 26304901
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors.
Olsson M; Beck S; Kogner P; Martinsson T; Carén H
Epigenetics; 2016; 11(1):74-84. PubMed ID: 26786290
[TBL] [Abstract][Full Text] [Related]
31. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
Brodeur GM; Pritchard J; Berthold F; Carlsen NL; Castel V; Castelberry RP; De Bernardi B; Evans AE; Favrot M; Hedborg F
Prog Clin Biol Res; 1994; 385():363-9. PubMed ID: 7972232
[No Abstract] [Full Text] [Related]
32. Current aspects of biology, risk assessment, and treatment of neuroblastoma.
Haase GM; Perez C; Atkinson JB
Semin Surg Oncol; 1999 Mar; 16(2):91-104. PubMed ID: 9988866
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
Peinemann F; van Dalen EC; Tushabe DA; Berthold F
Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: a single-institution experience.
Rosenbaum DG; Abramson SJ; DeLappe E; Teruya-Feldstein J; La Quaglia MP; Fox JJ; Price AP
AJR Am J Roentgenol; 2013 Jul; 201(1):W141-6. PubMed ID: 23789686
[TBL] [Abstract][Full Text] [Related]
35. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
Applebaum MA; Vaksman Z; Lee SM; Hungate EA; Henderson TO; London WB; Pinto N; Volchenboum SL; Park JR; Naranjo A; Hero B; Pearson AD; Stranger BE; Cohn SL; Diskin SJ
Eur J Cancer; 2017 Feb; 72():177-185. PubMed ID: 28033528
[TBL] [Abstract][Full Text] [Related]
36. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
Thompson D; Vo KT; London WB; Fischer M; Ambros PF; Nakagawara A; Brodeur GM; Matthay KK; DuBois SG
Cancer; 2016 Mar; 122(6):935-45. PubMed ID: 26709890
[TBL] [Abstract][Full Text] [Related]
37. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
[TBL] [Abstract][Full Text] [Related]
38. Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk.
Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
J Pediatr Hematol Oncol; 2004 Jan; 26(1):35-9. PubMed ID: 14707711
[TBL] [Abstract][Full Text] [Related]
39. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
40. Significance of pleural effusion in neuroblastoma.
Gupta H; Conrad J; Khoury JD; McGregor LM; Krasin MJ; Dome JS; Santana VM; Davidoff AM
Pediatr Blood Cancer; 2007 Dec; 49(7):906-8. PubMed ID: 17417797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
